Key facts
- AnthroTek’s last known valuation is $14.2M (Jun 2025).
- It has raised $1.5M; the latest was Seed Round ($1.3M) in Jun 2025.
- Notable investors include Cambridge Independent Science and Technology Awards.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for AnthroTek
- ·The full record, as it builds
Funding rounds
No funding rounds for AnthroTek are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AnthroTek
Operator of a hyper-realistic silicone solutions company intended to revolutionize medical simulation, prosthetics, robotics, and cinematic effects through advanced material science and cutting-edge technology. The company offers custom-built, ultra-realistic silicone replicas using AI, 3D modeling, and proprietary material science, enabling customers to access lifelike surgical training tools, realistic prosthetics, humanoid robotics skins, and cinematic props that elevate performance, precision, and immersion across various industries.
- Sector
- Business Products and Services (B2B)
- HQ
- Newmarket, United Kingdom
- Founded
- 2024
- Employees
- 8
- Website
- thefaceforge.co.uk/
- Ownership
- Privately Held (backing)
AnthroTek doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AnthroTek shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AnthroTek in its N-PORT filings yet. We sweep new filings monthly.